Product Launch

Mission Pharmacal Launches New Formulation of Kidney Stone Treatment, Urocit(R)-K 15 mEq

February 17, 2010

Maximum-strength, more convenient option available to help increase patient compliance
 

Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card

November 24, 2009

Customized dosage regimen will aid in patient compliance
 

Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America

November 11, 2009

European Launch Ongoing -- Initial Clinician And Patient Feedback Very Positive
 

Medtronic Introduces MASTERGRAFT® Strip for Spinal Surgeries

November 11, 2009

Provides surgeons increased flexibility for bone grafting in complex cases
 

AssureRx Launches First Personalized Medicine Product

October 22, 2009

GeneSightRx provides therapeutic decision-making support for physicians prescribing psychiatric medications
 

Allos Therapeutics Announces U.S. Availability of FOLOTYN for Relapsed or Refractory Peripheral T-Cell Lymphoma

October 05, 2009

FOLOTYN is the first and only drug approved by the FDA for this indication
 

Bayer Introduces CONTOUR USB

September 21, 2009

The First Blood Glucose Meter With Unique Plug & Play Diabetes Management Software
 

Merck Sharp & Dohme Launches SAFLUTAN (tafluprost) in International Markets

September 03, 2009

The First Preservative-Free Prostaglandin Eye Drop for the Treatment of Elevated Intraocular Pressure
 

Sagent Pharmaceuticals Announces Launch of Adenosine Injection, USP, in 6 mg per 2 mL Single-Dose Vials

September 01, 2009

Vial offering expands upon Sagent's full line of latex-free adenosine syringe products
 

Bausch & Lomb Surgical Launches the Akreos(R) AO Micro Incision IOL

August 03, 2009

Award winning, innovative addition to the Akreos(R) family
 

Promius Pharma Launches Promiseb Cream

July 28, 2009

Transforming the Treatment of Seborrheic Dermatitis
 

Adamis Pharmaceuticals Launches and Ships Pre-Filled Epinephrine Syringe

July 23, 2009

Management Forecasts Profitability Within 12 Months of Sales Launch
 

Abbott Receives CE Mark for Company's Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position

June 23, 2009

Broad Size Matrix of XIENCE PRIME to be Launched in Europe in the Third Quarter